Prospectus Initial Public Offering of Shares in Lumos Diagnostics Holdings Limited ACN 630 476 970

prospectus Initial public offering of shares in Lumos Diagnostics Holdings Limited ACN 630 476 970 Joint Lead Managers and Underwriter Australian Legal Adviser Financial adviser B Important Notices The Offer investors are set out in Section 5. There may be risk factors in addition to these that should be considered in light of your personal The Offer contained in this Prospectus is an invitation for you to apply circumstances. for fully paid ordinary shares (Shares) in Lumos Diagnostics Holdings Limited ACN 630 476 970 (the Company or Lumos). This Prospectus You should also consider the assumptions underlying the Forecast is issued by the Company and Lumos Diagnostics SaleCo Limited Financial Information set out in Section 4 and the risk factors set out ACN 650 279 511 (SaleCo). See Section 7.1 for further information on in Section 5 that could affect Lumos’ business, financial condition and the Offer, including as to details of the securities that will be issued results of operations. and transferred under this Prospectus. No person named in this Prospectus, nor any other person, Lodgement and Listing guarantees the performance of Lumos, the repayment of capital by Lumos or the payment of a return on the Shares. This Prospectus is dated Monday, 7 June 2021 and copy was lodged with the Australian Securities and Investments Commission (ASIC) on No person is authorised to give any information or make any that date (Prospectus Date). representation in connection with the Offer which is not contained in this Prospectus. Any information or representation not so contained Lumos will apply to the ASX within seven days after the Prospectus may not be relied on as having been authorised by Lumos or SaleCo, Date for admission of the Company to the Official List and quotation any of either of their Directors, officers, employees, advisers, agents, of the Shares on the ASX (Listing). partners, consultants, representatives, the Joint Lead Managers, any None of ASIC, the ASX or their respective officers take any other Lead Manager Parties (defined below) or any other person in responsibility for the content of this Prospectus or for the merits connection with the Offer. of the investment to which this Prospectus relates. Statements of past performance Lumos, SaleCo, each of their respective directors and officers, This Prospectus includes information regarding the past performance Computershare Investor Services Pty Limited (Share Registry) and of Lumos. Past performance information given in this Prospectus Bell Potter Securities Limited and Wilsons Corporate Finance Limited is given for illustrative purposes only. Investors should be aware (the Joint Lead Managers) disclaim all liability, whether in negligence that past performance does not represent, and should not be relied or otherwise, to persons who trade Shares before receiving their upon as being indicative of, future performance. Actual results could holding statement. differ materially from the past performance information contained in Expiry Date this Prospectus. This Prospectus expires on the date that is 13 months after the Forward-looking statements Prospectus Date (Expiry Date). No Shares will be issued or transferred No person is authorised to give any information or make any on the basis of this Prospectus after the Expiry Date. representation in connection with the Offer which is not contained in Exposure Period this Prospectus. Any information or representation not so contained may not be relied on as having been authorised by Lumos, SaleCo, The Corporations Act prohibits Lumos from processing applications the Directors, the SaleCo Directors, the Joint Lead Managers or any to subscribe for, or acquire, Shares offered under this Prospectus other person in connection with the Offer. You should rely only on (Applications) in the seven day period after lodgement of this information in this Prospectus when deciding whether to invest in Prospectus with ASIC (Exposure Period). This Exposure Period may Shares. Except as required by law, and only to the extent so required, be extended by ASIC by up to a further seven days. neither the Company nor any other person warrants or guarantees the The purpose of the Exposure Period is to enable this Prospectus future performance of Lumos, or any return on any investment made to be examined by market participants prior to the raising of funds. pursuant to this Prospectus. The examination may result in the identification of deficiencies in this This Prospectus contains forward-looking statements which are Prospectus, in which case any Application may need to be dealt with statements that may be identified by words such as “may”, “will”, in accordance with section 724 of the Corporations Act. “would”, “should”, “could”, “believes”, “estimates”, “expects”, “intends”, Applications received during the Exposure Period will not be processed “plans”, “anticipates”, “predicts”, “outlook”, “forecasts”, “guidance” until after the expiry of the Exposure Period. No preference will be and other similar words that involve risks and uncertainties. conferred on any Applications received during the Exposure Period. The Forecast Financial Information is an example of forward-looking statements. These statements are based on an assessment of Not investment advice present economic and operating conditions and on a number of best estimate assumptions regarding future events and actions that, at The information contained in this Prospectus is not financial product the Prospectus Date, are expected to take place (including the key advice and does not take into account the investment objectives, assumptions set out in Section 4). financial situation or particular needs (including financial and tax issues) of any prospective investor. No person who has made any forward-looking statements in this Prospectus (including Lumos) has any intention to update or revise It is important that you read this Prospectus carefully and in its forward-looking statements, or to publish prospective financial entirety before deciding whether to invest in Lumos. In particular, information in the future, regardless of whether new information, in considering the prospects of Lumos, you should consider the future events or any other factors affect the information contained in risk factors that could affect the performance of Lumos. You should this Prospectus, other than to the extent required by law. carefully consider these risks in light of your investment objectives, financial situation and particular needs (including financial and tax Such forward-looking statements are not guarantees of future issues) and seek professional guidance from your stockbroker, performance and involve known and unknown risks, uncertainties, solicitor, accountant, financial adviser or other independent assumptions and other important factors, many of which are beyond professional adviser before deciding whether to invest in the Shares. the control of Lumos, the directors and management of Lumos and Some of the key risk factors that should be considered by prospective SaleCo. Forward-looking statements should therefore be read in conjunction with, and are qualified by reference to, Sections 4 and 5, Lumos Diagnostics Prospectus 1 and other information in this Prospectus. Lumos and SaleCo cannot The Lead Manager Parties are involved in, or in the provision of, a and do not give any assurance that the results, performance wide range of financial services and businesses including (without or achievements expressed or implied by the forward-looking limitation) securities trading and brokerage activities and providing statements contained in this Prospectus will actually occur and retail, private banking, commercial and investment banking, investors are cautioned not to place undue reliance on these forward- investment management, corporate finance, securities issuing, credit looking statements. and derivative, trading and research products and services, including (without limitation) to, or in connection with, persons directly or Rounding indirectly involved with the Offer (such as Existing Securityholders A number of figures, amounts, percentages, estimates, calculations and members of the Board) or interests associated with such of value and fractions in this Prospectus are subject to the effect of persons, out of which conflicting interests or duties may arise. In the rounding. Accordingly, the actual calculation of these figures may ordinary course of these activities, each of the Lead Manager Parties differ from the figures set out in this Prospectus. may at any time hold long or short positions, and may trade or otherwise effect transactions, for its own account or the accounts of No offering where offering would be illegal customers, including (without limitation) in debt or equity securities, loans, financing arrangements, or other financial accommodation, This Prospectus does not constitute an offer or invitation in any place financial products or services, in connection with, or which rely on the in which, or to any person to whom, it would not be lawful to make performance of obligations by, interests associated with the Existing such an offer or invitation. No action has been taken to register or Securityholders, members of the Board or other persons that may be qualify the Shares or the Offer, or to otherwise permit a public offering involved in the Offer. of the Shares in any jurisdiction outside Australia. The distribution of this Prospectus (including in electronic form) outside Australia

Load more